medigraphic.com
SPANISH

Medicina & Laboratorio

ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

<< Back Next >>

Medicina & Laboratorio 2023; 27 (1)

Metastatic lesions to the thyroid gland. Case series

Vélez-Hoyos A, Agredo-Delgado V, Ariza-Gutiérrez A, Duque-Fisher CS, Dueñas-Muñoz JP, Tobón-Ospina C, Román-González A
Full text How to cite this article

Language: Spanish
References: 14
Page: 25-32
PDF size: 361.51 Kb.


Key words:

hyroid gland, renal cell carcinoma, melanoma, ductal carcinoma, neoplasm metastasis.

ABSTRACT

Metastatic lesions represent up to 3% of malignant tumors of the thyroid gland. Most cases originate from lung and renal cell tumors. The diagnostic approach implies a high clinical suspicion in patients with known primaries, however, it can be the initial manifestation of an extensive undiagnosed malignant disease in up to 20% to 40% of patients. Fine-needle biopsy has shown good performance for the diagnosis of metastatic nodules. The prognosis and the option of surgical treatment depend on the local control of the primary condition and the state of the associated systemic disease, therefore it must be individualized. In general, up to 80% of patients with thyroid involvement have multi-organ metastatic disease and surgical treatment is intended to be palliative to prevent complications resulting from local extension of the disease to structures of the upper aerodigestive tract in the neck. A case series of six patients with metastatic lesions to the thyroid gland with primaries in the kidney, breast and melanomas is presented below.


REFERENCES

  1. Hegerova L, Griebeler ML, Reynolds JP,Henry MR, Gharib H. Metastasis to the thyroidgland: report of a large series from the Mayo Clinic.Am J Clin Oncol 2015;38:338-342. https://doi.org/10.1097/COC.0b013e31829d1d09.

  2. Lee MW, Batoroev YK, Odashiro AN, NguyenGK. Solitary metastatic cancer to the thyroid: areport of five cases with fine-needle aspirationcytology. Cytojournal 2007;4:5. https://doi.org/10.1186/1742-6413-4-5.

  3. Rahman M, Okada AR, Guan K, Tauchi-NishiP. Metastatic neoplasms to the thyroid diagnosedby fine-needle aspiration/core needlebiopsy: Clinicopathologic and cytomorphologiccorrelation. Cytojournal 2017;14:16.https://cytojournal.com/metastatic-neoplasmsto-the-thyroid-diagnosed-by-fine-needle-aspiration-core-needle-biopsy-clinicopathologicand-cytomorphologic-correlation/.

  4. Kim TY, Kim WB, Gong G, Hong SJ, ShongYK. Metastasis to the thyroid diagnosed byfine-needle aspiration biopsy. Clin Endocrinol(Oxf) 2005;62:236-241. https://doi.org/10.1111/j.1365-2265.2005.02206.x.

  5. Nixon IJ, Coca-Pelaz A, Kaleva AI, TriantafyllouA, Angelos P, Owen RP, et al. Metastasisto the thyroid gland: A critical review. AnnSurg Oncol 2017;24:1533-1539. https://doi.org/10.1245/s10434-016-5683-4.

  6. Bozbora A, Barbaros U, Kaya H, Erbil Y, KapranY, Ozbey N, et al. Thyroid metastasisof malignant melanoma. Am J Clin Oncol2005;28:642-643. https://doi.org/10.1097/01.coc.0000159560.52040.18.

  7. Miiji LO, Nguyen GK. Metastatic melanomaof the thyroid mimicking a papillary carcinomain fine-needle aspiration. Diagn Cytopathol2005;32:374-376. https://doi.org/10.1002/dc.20261.

  8. Plonczak AM, DiMarco AN, Dina R, GujralDM, Palazzo FF. Breast cancer metastasesto the thyroid gland - An uncommon sentinelfor diffuse metastatic disease: a case reportand review of the literature. J Med Case Rep2017;11:269. https://doi.org/10.1186/s13256-017-1441-x.

  9. Silverberg SG, Vidone RA. Carcinoma of thethyroid in surgical and postmortem material.Analysis of 300 cases at autopsy and literaturereview. Ann Surg 1966;164:291-299. https://doi.org/10.1097/00000658-196608000-00016.

  10. Krishna M. Diagnosis of metastatic neoplasms:an immunohistochemical approach. ArchPathol Lab Med 2010;134:207-215. https://doi.org/10.5858/134.2.207.

  11. Pecciarini L, Giulia-Cangi M, Doglioni C.Identifying the primary sites of metastaticcarcinoma: the increasing role of immunohistochemistry.Curr Diagn Pathol 2001;7:168-175. https://doi.org/https://doi.org/10.1054/cdip.2001.0079.

  12. Basu S, Alavi A. Metastatic malignant melanomato the thyroid gland detected by FDG-PET imaging.Clin Nucl Med 2007;32:388-389. https://doi.org/10.1097/01.rlu.0000259613.28127.f8.

  13. Nixon IJ, Whitcher M, Glick J, Palmer FL, ShahaAR, Shah JP, et al. Surgical management ofmetastases to the thyroid gland. Ann Surg Oncol2011;18:800-804. https://doi.org/10.1245/s10434-010-1408-2.

  14. Cichoń S, Anielski R, Konturek A, BarczyńskiM, Cichoń W. Metastases to the thyroidgland: seventeen cases operated on in a singleclinical center. Langenbecks Arch Surg2006;391:581-587. https://doi.org/10.1007/s00423-006-0081-1.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medicina & Laboratorio. 2023;27